Matches 51 - 100 out of 228 < 1 2 3 4 5 >


Match Document Document Title
5942254 Phosphorylated recombinant human β-casein expressed in a bacterial system  
The present invention provides a plasmid containing a promoter sequence, a nucleotide sequence encoding an exogenous protein, and a nucleotide sequence encoding an enzyme capable of modifying the...
5834427 Casein phosphopeptide, casein containing same and process for the preparation thereof  
The present invention relates to a purified casein phosphopeptide(CPP) having a novel amino acid sequence and a purified casein including same wherein the 25th Arg from N-terminal in a...
5807702 Method for expressing phosphorylated recombinant human β-casein in a bacterial system  
The present invention provides a method of producing phophorylated, recombinant human β-casein having 3 to 5 phosphates in a bacterial cell using a single vector containing in tandem both the...
5780439 Whey protein hydrolysates and mixtures thereof with casein and/or soy protein hydrolysates  
A whey protein hydrolysate is described which is free of allergenics while preserving the structures susceptible of exerting anticipatory regulations to maximize the tolerance and protein...
5773577 Products comprising substrates capable of enzymatic cross-linking  
Polymers are provided comprising protein polymers comprising blocks of repeating units and sequences comprising amino acids, individually or in defined sequences, capable of enzyme catalyzed...
5719031 Dye labeled polymers as reagents for measuring polymer degradation  
This invention relates to polymers labeled with fluorescent dye to the point that significant fluorescence quenching occurs, such that degradation of the polymer results in fluorescence...
5712250 Product for inhibition of human rotavirus infection  
An enteral nutritional product containing either bovine κ-casein or human κ-casein at a concentration greater than that found in human or bovine milk and sufficient to inhibit infection of...
5710044 Plasmid for expressing phosphorylated recombinant proteins in a bacterial system  
The present invention provides a plasmid containing a promoter sequence, a nucleotide sequence encoding an exogenous protein, and a nucleotide sequence encoding an enzyme capable of modifying the...
5707968 Inhibition of attachment of H.influenzae to human cells  
The attachment of H. influenzae to human cells, such as oropharyngeal cells, may be inhibited by native human β-casein, a recombinant form of human β-casein, and hydrolysates of both. The human...
5703212 Preventive for circulatory diseases  
A preventive for circulatory diseases which can prevent the onset of circulatory diseases, particularly cerebral stroke, without causing adverse effects such as blood-pressure fluctuation. The...
5683984 Enteral tube feeding composition with a native micellar casein protein component  
An enteral composition of protein, glucides, lipids and minerals, which is suitable for tube feeding, employs native micellar casein as the protein. The composition is prepared by obtaining native...
5681586 Enzyme-modified soy and soy/casein combination healing compositions  
A pharmaceutical composition comprising an improved modified protein sol is used for treating and enhancing the healing of arthritis and cutaneous acne. Prior to being modified, a protein is...
5643880 Product for inhibition of attachment of H. influenzae to human cells  
The attachment of H. influenzae to human cells, such as oropharyngeal cells, may be inhibited by native human β-casein, a recombinant form of human β-casein, and hydrolysates of both. The human...
5578577 Method for storing labile proteins  
The present invention relates to improved specific binding assay methods, kits and devices utilizing chromatographically mobile specific binding reagents labelled with colloidal particles....
5576300 Method for inhibition of human rotavirus infection  
A method of preventing or treating infection by human rotavirus by administering an enteral nutritional product containing either bovine κ-casein or human κ-casein at a concentration greater than...
5538952 Inhibition of infection of mammalian cells by respiratory syncytial virus  
The infection of mammalian cells by RSV may be inhibited by native human β-casein, a recombinant form of human β-casein, and hydrolysates of both. The human β-casein or hydrolysate may be...
5523293 Soy protein-based thermoplastic composition for preparing molded articles  
The invention provides biodegradable, thermoplastic compositions made of the reaction product of soybean protein and a carbohydrate filler, a reducing agent, a plasticizer, water, and optional...
5506209 Product for inhibition of infection of mammalian cells by respiratory syncytial virus  
The infection of mammalian cells by RSV may be inhibited by native human β-casein, a recombinant form of human β-casein, and hydrolysates of both. The human β-casein or hydrolysate may be...
5502163 Control of secretion of milk  
A protein which inhibits milk secretion by lactating cows and which is present in the second (2A) significant peak when a nominally 10-30 KDa fraction of the whey proteins of the milk is resolved...
5473050 Denatured bovine serum albumin milk products and method therefor  
A method of producing denatured bovine serum albumin (BSA) milk products is disclosed which provides a container for containing the milk products and a source of heating the container for a period...
5412074 Silcone modified proteins  
Organofunctional silicone chains having an organic moiety on at least one end of the chains, are covalently linked to free amino groups of proteins by the organic moieties to provide a useful...
5391497 Human k-casein  
A cDNA sequence encoding human κ-casein.
5382601 Memantine-containing solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof  
The present invention provides solid pharmaceutical compositions in dosage form containing an active ingredient or principle, preferably memantine, which exhibit an extended two-phase release...
5344820 Infection protectant  
Disclosed herein is an infection protectant which is excellent in infection protective effects and is also safe. κ-Casein, a sialic-acid-conjugated protein derived from cow milk, and a...
5266685 Non-bitter protein hydrolyzates  
New protein hydrolyzates are produced by treating an aqueous solution of a protein hydrolyzate with an adsorptive resin functional to remove from the protein hydrolyzate bitter taste components,...
5227154 Phosphopeptides for the treatment of dental calculus  
A method of inhibiting dental calculus by applying to the teeth an oral composition containing a dental calculus inhibiting amount of one or more of the phosphopeptides SEQ.ID NO:1 to SEQ.ID NO:9,...
5219838 Method for inhibiting tyrosinase activity in treatment of skin  
An agent for tyrosinase inhibition which contains the effective quantity of enzymatic hydrolyzates of milk proteins, having a decomposition rate from 6% to 55% as expressed by the percentage of...
5216129 Production of kappa-caseino-glycomacropeptide  
Kappa-caseino-glycomacropeptide (CGMP) is industrially produced from a whey product concentrated in proteins partly freed from lactose by selective precipitation of the residual whey proteins with...
5173322 Reformed casein micelles  
Reformed casein micelles are produced from an aqueous solution or dispersion of commercially available processed casein by the sequential addition, over an extended period of time, of calcium ions...
5166132 Healing composition employing an enzyme-modified casein  
A topical use pharmaceutical composition and a process for its preparation, comprising an improved enzyme-modified casein sol. Prior to being enzyme-modified, the casein is solubilized and...
5144006 Oxidative folding of peptide and protein substrates using hydrocarbon sulfoxides  
Method for oxidative folding of peptide and protein substrates to form disulfide bonds using dimethyl sulfoxide and other equivalent sulfoxides as mild oxidizing agents.
5130123 Dentifrice  
A dentifrice composition useful in inhibiting caries and ginivitis comprising a caries and gingivitis inhibiting amount of a material selected from the group consisting of a water soluble salt of...
5124438 Chemically modified proteins and colorant formulations containing the same  
Chemically modified proteins obtainable by reacting casein, collagen, gelatin, albumin or mixtures thereof (a) with 0.5 to 15% by weight of chlorine or of a compound which liberates chlorine under...
5075424 Process for producing κ-casein glycomacropeptides  
A process for producing κ-casein glycomacropeptides which comprises adjusting the pH of a solution of milk starting materials containing the κ-casein glycomacropeptides to below 4, treating the...
5071960 High molecular weight protein/fatty acid condensation products which are very well tolerated by the skin and mucosa  
High molecular weight protein/fatty acid condensation products obtained by reaction of one mole of a protein hydrolysate of average molecular mass 3,000 to 7,000 with 0.5 to 3, preferably 2 to...
5017559 Agent for blocking nonspecific adsorption, process for preparing thereof and method of blocking nonspecific adsorption  
The present invention provides an agent utilizing for immunological assays in medical fields for blocking nonspecific adsorption, a process for preparing thereof and a method of blocking...
5015628 Anticariogenic phosphopeptides  
A phosphopeptide or a salt thereof the phosphopeptide having from 5 to 30 amino acids including the sequence A-B-C-D-Ewhere A, B, C, D and E are independently phosphoserine, phosphothreonine,...
4985405 Therapeutic product based on organic silicon derivatives  
Therapeutic produced based on an organic derivative of silicon, notably of silanol complexed with an amino acid, with a pharmaceutically acceptable salt of such an acid, or with a protide. The...
4980450 Phosphopeptides from casein-based raw material  
The method consists in subjecting the raw material (milk or retentate) to enzymatic hydrolysis by means of at least one proteolytic enzyme able to reproduce the proteic digestion occuring in vivo...
4956480 7-amino-4-methyl-coumarin-3-carboxyalkyl derivates and fluorescent conjugates thereof  
A novel compound having the formula (I): ##STR1## or a reactive derivative or functional equivalent thereof, wherein m is an integer from 1 to 4, and R1 and R2 are same or different and selected...
4906616 Hydrolyzed sodium casein compositions for dialysis procedures  
A medicinal composition, particularly but not exclusively for use in fluids for medical dialysis, contains, as an agent for maintaining the osmolality of the fluid, a protein hydrolysate resulting...
4873316 Isolation of exogenous recombinant proteins from the milk of transgenic mammals  
This invention relates to the production of recombinant proteins in mammals' milk. Particularly, this invention relates to an expression system comprising the mammal's casein promoter which when...
4839345 Hydrated adhesive gel and method for preparing the same  
This invention relates to a hydrated adhesive gel using a product which is obtained by reacting an aqueous solution consisting essentially of protein having amino groups at the side chains...
4818531 Growth hormone and thyroid hormone  
This invention describes a method of increasing the feed intake of pigs, chickens, or dairy cattle, which have elevated levels of growth hormone, by administering a thyroid-active substance.
4816177 Treating agent for liquid media  
An agent is disclosed that is useful for treating liquid media, e.g., dechlorinating aqueous media. The agent contains at least one salt from the sulfur oxide family, such as sodium sulfite. In...
4777243 Immuno stimulant substances derived from bovine casein and compositions containing the same  
New immunostimulant substances are obtained by hydrolysing delipidized bovine casein with a proteolytic enzyme and fractionating the product.
4734398 Follicular regulating protein  
A protein moiety having a molecular weight of from 12,000 to 15,000 inhibits aromatase levels, stimulates 3β-ol dehydrogenase levels and modulates the formation of mature ova substantially...
4713254 Casein-soluble protein complex  
A casein-soluble protein complex is prepared by raising the pH of an aqueous medium containing casein and soluble protein to within the range of 7.0 to 8.0, heating to a temperature in the range...
4691011 Water-dispersible hydrophilic milk protein product  
According to the invention, a milk protein product is provided. The milk protein product has water-dispersible and hydrophilic properties and contains substantially no serum. The milk protein...
4673707 Synthetic polymers with glycoside side chains  
Derivatized polymers containing glycoside side chains linked to the polymer by ether, sulfide, or amine linkages are prepared by reacting a polymer containing alcohol, thiol, and/or amine groups...

Matches 51 - 100 out of 228 < 1 2 3 4 5 >